19-21405133-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000392288.7(ZNF493):c.35C>A(p.Pro12Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000992 in 1,612,582 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000392288.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF493 | NM_001076678.3 | c.35C>A | p.Pro12Gln | missense_variant | 2/4 | ENST00000392288.7 | NP_001070146.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF493 | ENST00000392288.7 | c.35C>A | p.Pro12Gln | missense_variant | 2/4 | 1 | NM_001076678.3 | ENSP00000376110 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000593 AC: 9AN: 151678Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000798 AC: 2AN: 250718Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135614
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1460904Hom.: 0 Cov.: 34 AF XY: 0.00000550 AC XY: 4AN XY: 726788
GnomAD4 genome AF: 0.0000593 AC: 9AN: 151678Hom.: 0 Cov.: 32 AF XY: 0.0000675 AC XY: 5AN XY: 74052
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 16, 2024 | The c.35C>A (p.P12Q) alteration is located in exon 2 (coding exon 2) of the ZNF493 gene. This alteration results from a C to A substitution at nucleotide position 35, causing the proline (P) at amino acid position 12 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at